Indeferimento mantido em recurso
#9.2.4
MANTIDO O INDEFERIMENTO UMA VEZ QUE NÃO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.
02/25/2014
RPI 2251
Back to search
Application data
Number
PI9613022Type
Invention Patent
Filing
12/04/1996
Publication
-
PCT
IB1996001353 Progress at the INPI
- Filing12/04/96
- Publication
- Examination
- Refused02/25/14
- Grant
- In force
The application was refused on 02/25/2014 and the appeal did not change the decision. The invention was never patented and the technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 02/25/2014. We update with every new RPI gazette, published weekly.
Applicants and inventors
Applicants
Pfizer Inc.
US
Raqualia Pharma Inc.
JP
Inventors
No inventors listed.
Technical data
IPC Classification
No IPC classification.
Prosecution history
Publications in the Brazilian Industrial Property Gazette (RPI).
Indeferimento
#9.2
Indefiro o pedido de acordo com o(s) artigo(s) 8º,11, 24,25 e 37 da LPI.
04/16/2013
RPI 2206
Transferência deferida
#25.1
Transferido de: Pfizer Inc.
09/13/2011
RPI 2123
Notificação de pedido dividido
#2.4
Notificação da entrada da Fase Nacional (1.3):RPI 1488 (13/07/1999); Exigências técnicas (6.1): RPI's 1874 (15/12/2006) e 1892 (10/04/2007)
07/13/2010
RPI 2062
Exigência - art. 36 da LPI
#6.1
04/10/2007
RPI 1892
Exigência - art. 36 da LPI
#6.1
12/05/2006
RPI 1874
Related
Patent monitoring
Track this patent in real time.
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.